Sophia Genetics raised €94M in a Series D+ round in Oct 2020. The company is based in Saint-Sulpice, Switzerland. Investors in the round: aMoon Fund. Data as of 7 Aug 2026.
Confidence is the weaker of amount-FX and source evidence (the cascade rule). See methodology.
